NuMedii

About:

NuMedii is a biotechnology company that discovers and de-risks effective drugs by translating life sciences big data into therapies.

Website: http://numedii.com

Twitter/X: NuMedii

Top Investors: Lightspeed Venture Partners, Seraph Group, Life Science Angels, Claremont Creek Ventures, TSVC

Description:

NuMedii is a biotechnology company that discovers and de-risks effective new drugs by translating life sciences big data into therapies. The Company’s proprietary and dynamic Big Data technology, developed in Atul Butte’s lab at Stanford University and licensed exclusively to NuMedii. It utilizes hundreds of millions of raw human, biological, pharmacological, and clinical data points. The company was founded in 2008 and headquartered in San Mateo, California.

Total Funding Amount:

$5.5M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Menlo Park, California, United States

Founded Date:

2008-01-01

Contact Email:

busdev(AT)numedii.com

Founders:

Atul Butte, Gini Deshpande, Joel Dudley

Number of Employees:

11-50

Last Funding Date:

2015-08-17

IPO Status:

Private

Industries:

© 2025 bioDAO.ai